QID 377755

Date Published: 2023-01-05

QID 377755: IBM WebSphere Application Server Hypertext Transfer Protocol (HTTP) Header Injection Vulnerability (6618747)

IBM WebSphere Application Server and IBM WebSphere Application Server Liberty are vulnerable to HTTP header injection, caused by improper validation. This could allow an attacker to conduct various attacks against the vulnerable system, including cache poisoning and cross-site scripting.

Affected Products:
WebSphere Application Server Liberty Version 17.0.0.3 - 22.0.0.9
WebSphere Application Server Version 9.0.0.0 through 9.0.5.13
WebSphere Application Server Version 8.5.0.0 through 8.5.5.22
WebSphere Application Server Version 8.0.0.0 through 8.0.0.15
WebSphere Application Server Version 7.0.0.0 through 7.0.0.45

QID Detection Logic:(Authenticated)
It reads the fix xml file and WebSphereApplicationServer.properties to detect the vulnerable version and also checks for fix pack version.

This vulnerability allows the attacker to conduct various attacks against the vulnerable system, including cache poisoning and cross-site scripting.

CVSS V3 rated as Medium - 5.4 severity.

CVSS V2 rated as High - 6.4 severity.

Solution

Upgrade to minimal fix pack levels as required by interim fix and then apply Interim Fix PH46816 or Apply Fix Pack 9.0.5.14 or later for 9.0 versions, 8.5.5.23 or later for 8.5 versions, 8.0.0.15 or later for 8.0 versions and 7.0.0.45 or later for 7.0 versions.

Vendor References

6618747 - www.ibm.com/support/pages/node/6618747

CVEs related to QID 377755

CVE-2022-34165 |

Software Advisories

Advisory ID	Software	Component	Link
6618747			www.ibm.com/support/pages/node/6618747

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].